Ticagrelor Impurity 225 - Request Quote
Ticagrelor Impurity 225
| SZ CAT No: | SZ-T023340 |
| CAS No | NA |
| Mol.F. | C23H28F2N6O4S |
| Mol.Wt. |
522.6 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ticagrelor Impurity 225 is chemically (1R,2R,3R,5S)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol. Ticagrelor Impurity 225 is supplied with detailed characterization data compliant with regulatory guideline. Ticagrelor Impurity 225 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ticagrelor.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Ticagrelor Impurity 225
Purchase Ticagrelor Impurity 225
Ticagrelor Impurity 225 suppliers
Ticagrelor Impurity 225 manufacturers
Ticagrelor Impurity 225 price
Order Ticagrelor Impurity 225
Enquire Ticagrelor Impurity 225
Ticagrelor Impurity 225 cost
Ticagrelor Impurity 225 Supplier
Ticagrelor Impurity 225 Distributor
Ticagrelor Impurity 225 for Method Validation
Ticagrelor Reference Standard
Ticagrelor Impurity 225 for ANDA Filing
Ticagrelor Impurity 225 for Forced Degradation Studies
Ticagrelor Impurity 225 Identification Standards
Ticagrelor Impurity 225 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


